β-Caryophyllene Inhibits Oxaliplatin-Induced Peripheral Neuropathy in Mice: Role of Cannabinoid Type 2 Receptors, Oxidative Stress and Neuroinflammation

Peripheral neuropathy is an important adverse effect caused by some chemotherapeutic agents, including oxaliplatin (OXA). OXA-induced peripheral neuropathy (OIPN) is a challenging condition due to diagnostic complexities and a lack of effective treatment. In this study, we investigated the antiallodynic effect of β-caryophyllene (BCP), a cannabinoid type 2 (CB2) receptor agonist, in a mouse model of OIPN. BCP treatment inhibited OXA-induced mechanical and cold allodynia in both preventive and therapeutic drug treatment regimens. Experiments with the CB2 receptor agonist GW405833 confirmed the role of CB2 receptors in OIPN. The CB2 antagonist SR144528 abrogated the anti-nociceptive effect of BCP on mechanical allodynia, without impacting OXA-induced sensitivity to cold. BCP decreased neuroinflammation, as inferred from TNF, IL-1β, IL-6, and IL-10 profiling, and also reduced ROS production, lipid peroxidation, and 4-hydroxynonenal protein adduct formation in the spinal cords of OXA-treated mice. BCP did not affect the antitumor response to OXA or its impact on blood cell counts, implying that the cytotoxicity of OXA was preserved. These results underscore BCP as a candidate drug for OIPN treatment via CB2 receptor-dependent mechanisms, and anti-inflammatory and antioxidant responses in the spinal cord.

Dyadic Adjustment and Sexual Satisfaction in HPV Diagnosed Portuguese Women: A Longitudinal Study

This study examined the relationship between dyadic adjustment and sexual satisfaction, in Portuguese women diagnosed with human papillomavirus (HPV), using a 1-year longitudinal design. Women were assessed at the beginning of the study (N = 209), six months after (N = 178) and twelve months later (N = 105). A better dyadic adjustment predicted more sexual satisfaction but the inverse was not observed. Younger women (< 40 years) showed greater difficulties in dyadic adjustment, while older women (> 40 years) reported lower sexual satisfaction. Findings highlight the importance of intervening with couples, using different intervention programs according to women's age.

Dyadic Adjustment in HPV-Infected Women One Year After Diagnosis

Objective: This study examined the contribution of age, type of human papillomavirus (HPV), attachment, sexual satisfaction, and spirituality in dyadic adjustment in women with HPV from diagnosis to one year later. Method: This is a longitudinal study with three assessment moments: (T1) at the diagnosis appointment, (T2) six months after, and (T3) 12 months after the diagnosis. Participants answered a sociodemographic questionnaire as well as several other measures: HPV Knowledge Questionnaire (HPVQ), Papanicolaou Exam Knowledge Questionnaire (PEK-Q), Hospital Anxiety and Depression Scale (HADS), Courtauld Emotional Control Scale (CECS), Index of Sexual Satisfaction (ISS), Experiences in Close Relationship Scale-Short Form (ECR-S), Spiritual and Religious Attitudes in Dealing With Illness (SpREUK), and the Revised Dyadic Adjustment Scale (RDAS). Results: Age showed a positive impact on sexual dissatisfaction at T2. Sexual dissatisfaction at T1 predicted sexual dissatisfaction at T2 and dyadic adjustment at T3. Spirituality and insecure attachment at T1 negatively predicted insecure attachment at T2, and the latter predicted dyadic adjustment at T3. Conclusions: The results corroborate the need to assess the dyad when women are diagnosed with HPV. Only then it will be possible to design differentiated intervention programs that take into consideration women's age, attachment style, and sexual satisfaction. Interventions should also include women's partners to promote dyadic adjustment in this population.

Redox control of caspase-3 activity by thioredoxin and other reduced proteins

Caspases are cysteine proteinases that play a critical role in the execution phase of apoptosis. The active site cysteine residue must be reduced for caspase activity. Thioredoxins are redox proteins that catalyze the reduction of cysteine residues. We have examined the ability of various recombinant human thioredoxins to activate caspase-3. The EC(50) for caspase-3 activation by reduced thioredoxin-1 was 2.5 microM, by reduced glutathione 1.0 mM and by dithiothreitol 3.5 mM. A catalytic site redox-inactive mutant thioredoxin-1 was almost as active as thioredoxin-1 in activating caspase-3. Caspase activation was shown to correlate with the number of reduced cysteine residues in the thioredoxins. Reduced insulin and serum albumin were as effective on a molar basis as thioredoxin-1 in activating caspase-3. Thus, caspase-3 activation is not a specific effect of thioredoxins but is a property shared by other reduced proteins.